Transaction · 0001886794-26-000002

Dhaliwal Harpreet S.

Dhaliwal Harpreet S., CTOO, reported an open-market or private sale at Vaxcyte, Inc. involving 9743.000000 shares for an estimated $454890.93. Reported holdings after the transaction were 23928.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCTOO
PCVXVaxcyte, Inc.
Filing timeJan 02
Trade dateDec 31, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$46.46
Pre-filing
1mo ago -2.0%1w ago -2.0%1d ago -2.0%
Returns since
7d +0.0%30d +0.0%90d +25.9%180d +20.7%1y +34.7%

PCVX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PCVX since 2026-01-02Filed 244 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001886794-26-000002
Common Stock
Transaction date
Dec 31, 2025
Filed Jan 02, 2026, 09:21 PM · 2d delay
Shares
9.74k sh
$4.66k per share
Estimated value
-$45.4M
Computed from shares × price
Holdings after
23.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Reduction
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Technical Ops Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder…

  2. issuer, full information regarding the number of shares sold at each separate price.

  3. F2

    Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.

Original filing · 0001886794-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PCVX